Atrial fibrillation (AF) is a prevalent clinical arrhythmia disease and is an important cause of stroke, heart failure, and sudden death. Due to the insidious onset and no obvious clinical symptoms of AF, the status of AF diagnosis and treatment is not optimal. Early AF screening or detection is essential. Internet of Things (IoT) and artificial intelligence (AI) technologies have driven the development of wearable electrocardiograph (ECG) devices used for health monitoring, which are an effective means of AF detection. The main challenges of AF analysis using ambulatory ECG include ECG signal quality assessment to select available ECG, the robust and accurate detection of QRS complex waves to monitor heart rate, and AF identification under the interference of abnormal ECG rhythm. Through ambulatory ECG measurement and intelligent detection technology, the probability of postoperative recurrence of AF can be reduced, and personalized treatment and management of patients with AF can be realized. This work describes the status of AF monitoring technology in terms of devices, algorithms, clinical applications, and future directions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1109/TBME.2023.3321792 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Automatically optimized vectorcardiographic features are associated with recurrence of atrial fibrillation after electrical cardioversion.
Sci Rep
January 2025
Cardiocenter, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
Electrical cardioversion presents one of the treatment options for atrial fibrillation (AF). However, the early recurrence rate is high, reaching ~40% three months after the procedure. Features based on vectorcardiographic signals were explored to find association with early recurrence of AF.
View Article and Find Full Text PDFArtificial intelligence for hemodynamic monitoring with a wearable electrocardiogram monitor.
Commun Med (Lond)
January 2025
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
Background: The ability to non-invasively measure left atrial pressure would facilitate the identification of patients at risk of pulmonary congestion and guide proactive heart failure care. Wearable cardiac monitors, which record single-lead electrocardiogram data, provide information that can be leveraged to infer left atrial pressures.
Methods: We developed a deep neural network using single-lead electrocardiogram data to determine when the left atrial pressure is elevated.
Cardiac arrhythmia assessment with patch electrocardiogram versus insertable cardiac monitor: a cohort study in endurance athletes with atrial fibrillation.
BMJ Open
January 2025
Department of Medical Research Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway
Objectives: The objective of this study was to assess the quality of ECG recordings and the concordance between the automatic detection of cardiac arrhythmia episodes by a patch ECG and an insertable cardiac monitor.
Design: Prospective cohort study.
Setting And Participants: Endurance athletes diagnosed with paroxysmal atrial fibrillation (AF) and no other relevant comorbidities participating in a randomised controlled trial on the effects of training adaption.
Pre-procedural TMAO as a predictor for recurrence of atrial fibrillation after catheter ablation.
BMC Cardiovasc Disord
December 2024
Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, 223300, China.
Background: Numerous studies have demonstrated the significance of trimethylamine-N-oxide (TMAO) in the progression of atrial fibrillation (AF). However, the association between TMAO and AF recurrence (RAF) post-catheter ablation is not yet fully understood. This study aims to elucidate the predictive capability of pre-procedural TMAO levels in determining RAF following catheter ablation (CA).
View Article and Find Full Text PDFClinical Characteristics of Patients With Becker Muscular Dystrophy Having Pathogenic Microvariants or Duplications.
Neurol Genet
February 2025
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira.
Background And Objectives: Becker muscular dystrophy (BMD) is an allelic disorder of Duchenne muscular dystrophy (DMD) in which pathogenic variants in cause progressive worsening of motor dysfunction, muscle weakness and atrophy, and death due to respiratory and cardiac failure. BMD often has in-frame deletions that preserve the amino acid reading frame, but there are some cases with microvariants or duplications. In recent years, the importance of therapeutic development and care for BMD has been emphasized.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!